In the largest deal in its 33-year history, Gilead Sciences has agreed to pay $21 billion to acquire Immunomedics and...
Read moreAmgen, Astellas, AstraZeneca, Bayer, Boehringer Ingelheim, GSK, Institut De Recherches Servier, Janssen, Merck, and Novartis — inked an agreement to...
Read moreClinical trials for the AstraZeneca Oxford coronavirus vaccine, AZD1222, have resumed in the UK following confirmation by the Medicines Health...
Read moreRipeta and Wellcome are pleased to announce a collaborative effort to assess data and code availability in the manuscripts of...
Read moreThanks to its novel real-cum-virtual Marketplace concept euroPLX 73 Vienna will be one of the first pharma partnering events, if not...
Read moreNational Science and Technology Development Agency Thailand (NSTDA) is implementing the Government’s Thailand 4.0 initiative to promote strategic biotechnology growth...
Read moreRoche and Regeneron have partnered to develop, manufacture and distribute REGN-COV2, Regeneron’s investigational antiviral antibody combination, to people around the...
Read moreCryoport, Inc., a provider of temperature-controlled supply chain solutions for the life sciences, has signed an agreement to acquire MVE...
Read moreNetherlands-based Intravacc, a company active in translational research and development of viral and bacterial vaccines, has partnered with Buffalo, NY-based...
Read moreParexel, a provider of services from clinical through commercialization, has signed a new master service agreement (MSA) with Pfizer Inc....
Read morePharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.